Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00703300
Recruitment Status : Completed
First Posted : June 23, 2008
Last Update Posted : November 7, 2014
Information provided by (Responsible Party):
National Cancer Institute (NCI)